These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8005373)

  • 1. Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism.
    Prahalada S; Majka JA; Soper KA; Nett TM; Bagdon WJ; Peter CP; Burek JD; MacDonald JS; van Zwieten MJ
    Fundam Appl Toxicol; 1994 Feb; 22(2):211-9. PubMed ID: 8005373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a dopamine agonist on the development of Leydig cell hyperplasia in Sprague-Dawley rats.
    Dirami G; Teerds KJ; Cooke BA
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):169-77. PubMed ID: 8917689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulatory effect of luteinizing hormone on the development and maintenance of 5 alpha-reduced steroid-producing testicular interstitial cell tumors in Fischer 344 rats.
    Chatani F; Nonoyama T; Sudo K; Miyajima H; Takeyama M; Takatsuka D; Mori H; Matsumoto K
    Anticancer Res; 1990; 10(2A):337-42. PubMed ID: 2189360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species-specific mechanism in rat Leydig cell tumorigenesis by procymidone.
    Murakami M; Hosokawa S; Yamada T; Harakawa M; Ito M; Koyama Y; Kimura J; Yoshitake A; Yamada H
    Toxicol Appl Pharmacol; 1995 Apr; 131(2):244-52. PubMed ID: 7716766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antigonadotropic action of testosterone but not 7alpha-methyl-19-nortestosterone is attenuated through the 5alpha-reductase pathway in the castrated male rat pituitary gland.
    Bandivdekar AH; Karp R; Sundaram K; Kumar N
    J Androl; 2000; 21(2):268-75. PubMed ID: 10714822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.
    McConnell JD; Wilson JD; George FW; Geller J; Pappas F; Stoner E
    J Clin Endocrinol Metab; 1992 Mar; 74(3):505-8. PubMed ID: 1371291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the 5 alpha-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study.
    Uygur MC; Arik AI; Altuğ U; Erol D
    Steroids; 1998 Apr; 63(4):208-13. PubMed ID: 9589555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of drug-induced Leydig cell hyperplasia and neoplasia in the rat and some comparisons with man.
    Prentice DE; Meikle AW
    Hum Exp Toxicol; 1995 Jul; 14(7):562-72. PubMed ID: 7576816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism.
    Cook JC; Murray SM; Frame SR; Hurtt ME
    Toxicol Appl Pharmacol; 1992 Apr; 113(2):209-17. PubMed ID: 1561629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs.
    Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B
    Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leydig cell hyperplasia and adenoma formation: mechanisms and relevance to humans.
    Clegg ED; Cook JC; Chapin RE; Foster PM; Daston GP
    Reprod Toxicol; 1997; 11(1):107-21. PubMed ID: 9138629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
    Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
    Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Janus Kinase Inhibitor, Tofacitinib, on Testicular Leydig Cell Hyperplasia and Adenoma in Rats, and on Prolactin Signaling in Cultured Primary Rat Leydig Cells.
    Chapin RE; Ball DJ; Radi ZA; Kumpf SW; Koza-Taylor PH; Potter DM; Mark Vogel W
    Toxicol Sci; 2017 Jan; 155(1):148-156. PubMed ID: 27708194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole.
    Fort FL; Miyajima H; Ando T; Suzuki T; Yamamoto M; Hamashima T; Sato S; Kitazaki T; Mahony MC; Hodgen GD
    Fundam Appl Toxicol; 1995 Jul; 26(2):191-202. PubMed ID: 7589908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation of serum luteinizing hormone levels with the induction of Leydig cell tumors in rats by oxolinic acid.
    Yamada T; Nakamura J; Murakami M; Okuno Y; Hosokawa S; Matsuo M; Yamada H
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):146-54. PubMed ID: 7974488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide impairs spermatogenesis via reducing gene expression levels in testosterone synthesis pathway.
    Chiou TJ; Chu ST; Tzeng WF; Huang YC; Liao CJ
    Chem Res Toxicol; 2008 Aug; 21(8):1562-9. PubMed ID: 18630931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
    Dallob AL; Sadick NS; Unger W; Lipert S; Geissler LA; Gregoire SL; Nguyen HH; Moore EC; Tanaka WK
    J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.